Cyrcadia
Reno, US · Nevada corporation
Cyrcadia Health develops the Cyrcadia Breast Monitor, a pair of wearable breast patches that detect circadian temperature changes in breast tissue and apply machine learning algorithms to identify abnormal patterns, delivering results to health care providers. The product targets women seeking early breast health monitoring and is not currently available for sale in the United States.
Founders & leadership
RR
Rob RoyeaExecutive
JD
Jim D HolmesTreasurer and Corporate Secretary
JD
Jim D. HolmesNamed on SEC filing
Board
SM
Shyamali Mallick SinghalBoard director
MB
Matthew BenardisBoard director
CS
Constance SkidmoreBoard director
JM
John MoriartyBoard director
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2012–2015
▶$300KraisedDec 2015 · 1 investors · BiotechnologyRule 506(b)
▶$300KraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shyamali Mallick SinghalDirector
- Matthew BenardisDirector
- Constance SkidmoreDirector
- Rob RoyeaExecutive Officer, Director
- Jim D HolmesDirector
- John MoriartyDirector
- Offering amount
- $1.2M
- Amount sold
- $300K
- Minimum investment
- $50K
- First sale
- Nov 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2.1MraisedSep 2014 · 62 investors · BiotechnologyRule 506(b)
▶$2.1MraisedSep 2014 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim D. HolmesExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.1M
- Minimum investment
- $5K
- First sale
- Sep 2012
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Cyrcadia for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cyrcadia do?
- Cyrcadia Health develops the Cyrcadia Breast Monitor, a pair of wearable breast patches that detect circadian temperature changes in breast tissue and apply machine learning algorithms to identify abnormal patterns, delivering results to health care providers. The product targets women seeking early breast health monitoring and is not currently available for sale in the United States.
- How much funding has Cyrcadia raised?
- Cyrcadia has disclosed $2.4M raised across 2 rounds.
- Where is Cyrcadia headquartered?
- Cyrcadia is headquartered in Reno, US.
